Stress conditions typical of MASLD, such as lipid accumulation, oxidative stress, and inflammation, may upregulate BAG3 expression, thereby impacting the fibrogenic microenvironment. The gene discussed is BAG3; the disease is metabolic dysfunction-associated steatotic liver disease.